Impact of Primary Coronary Angioplasty Delay on Myocardial Salvage, Infarct Size, and Microvascular Damage in Patients With ST-Segment Elevation Myocardial Infarction Insight From Cardiovascular Magnetic Resonance

被引:221
作者
Francone, Marco [1 ]
Bucciarelli-Ducci, Chiara [2 ,3 ,5 ]
Carbone, Iacopo [1 ]
Canali, Emanuele [2 ,3 ]
Scardala, Raffaele [2 ,3 ]
Calabrese, Francesca A. [1 ]
Sardella, Gennaro [4 ]
Mancone, Massimo [4 ]
Catalano, Carlo [1 ]
Fedele, Francesco [2 ,3 ]
Passariello, Roberto [1 ]
Bogaert, Jan [6 ]
Agati, Luciano [2 ,3 ]
机构
[1] Univ Roma La Sapienza, Cardiovasc Magnet Resonance Unit, Dept Radiol Sci, I-00161 Rome, Italy
[2] Univ Roma La Sapienza, Cardiac Imaging Unit, I-00161 Rome, Italy
[3] Univ Roma La Sapienza, Div Cardiovasc, I-00161 Rome, Italy
[4] Univ Roma La Sapienza, Catheterizat Lab, Dept Cardiol Sci, I-00161 Rome, Italy
[5] Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6LY, England
[6] Univ Hosp Gasthuisberg, Dept Med Imaging, B-3000 Louvain, Belgium
关键词
myocardial salvage; myocardial infarction; microvascular injury; cardiovascular magnetic resonance; time to reperfusion; TIME-TO-TREATMENT; NO-REFLOW; INTERVENTION; RISK; ENHANCEMENT; OBSTRUCTION; THERAPY; TRANSMURALITY; REPERFUSION; STRATEGIES;
D O I
10.1016/j.jacc.2009.08.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We investigated the extent and nature of myocardial damage by using cardiovascular magnetic resonance (CMR) in relation to different time-to-reperfusion intervals. Background Previous studies evaluating the influence of time to reperfusion on infarct size (IS) and myocardial salvage in patients with ST-segment elevation myocardial infarction (STEMI) have yielded conflicting results. Methods Seventy patients with STEMI successfully treated with primary percutaneous coronary intervention within 12 h from symptom onset underwent CMR 3 +/- 2 days after hospital admission. Patients were subcategorized into 4 time-to-reperfusion (symptom onset to balloon) quartiles: <= 90 min (group I, n = 19), >90 to 150 min (group II, n = 17), >150 to 360 min (group III, n = 17), and >360 min (group IV, n = 17). T2-weighted short tau inversion recovery and late gadolinium enhancement CMR were used to characterize reversible and irreversible myocardial injury (area at risk and IS, respectively); salvaged myocardium was defined as the normalized difference between extent of T2-weighted short tau inversion recovery and late gadolinium enhancement. Results Shorter time-to-reperfusion (group I) was associated with smaller IS and microvascular obstruction and larger salvaged myocardium. Mean IS progressively increased overtime: 8% (group I), 11.7% (group II), 12.7% (group III), and 17.9% (group IV), p = 0.017; similarly, MVO was larger in patients reperfused later (0.5%, 1.5%, 3.7%, and 6.6%, respectively, p = 0.047). Accordingly, salvaged myocardium markedly decreased when reperfusion occurred >90 min of coronary occlusion (8.5%, 3.2%, 2.4%, and 2.1%, respectively, p = 0.004). Conclusions In patients with STEMI treated with primary percutaneous coronary intervention, time to reperfusion determines the extent of reversible and irreversible myocardial injury assessed by CMR. In particular, salvaged myocardium is markedly reduced when reperfusion occurs >90 min of coronary occlusion. (J Am Coll Cardiol 2009;54:2145-53) (C) 2009 by the American College of Cardiology Foundation
引用
收藏
页码:2145 / 2153
页数:9
相关论文
共 33 条
[1]   Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction [J].
Abdel-Aty, H ;
Zagrosek, A ;
Schulz-Menger, J ;
Taylor, AJ ;
Messroghli, D ;
Kumar, A ;
Gross, M ;
Dietz, R ;
Friedrich, MG .
CIRCULATION, 2004, 109 (20) :2411-2416
[2]   T2-weighted cardiovascular magnetic resonance imaging [J].
Abdel-Aty, Hassan ;
Simonetti, Orlando ;
Friedrich, Matthias G. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2007, 26 (03) :452-459
[3]   INFLUENCE OF RESIDUAL PERFUSION WITHIN THE INFARCT ZONE ON THE NATURAL-HISTORY OF LEFT-VENTRICULAR DYSFUNCTION AFTER ACUTE MYOCARDIAL-INFARCTION - A MYOCARDIAL CONTRAST ECHOCARDIOGRAPHIC STUDY [J].
AGATI, L ;
VOCI, P ;
BILOTTA, F ;
LUONGO, R ;
AUTORE, C ;
PENCO, M ;
IACOBONI, C ;
FEDELE, F ;
DAGIANTI, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (02) :336-342
[4]   Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging - Histopathological and displacement encoding with stimulated echoes (DENSE) functional validations [J].
Aletras, AH ;
Tilak, GS ;
Natanzon, A ;
Hsu, LY ;
Gonzalez, FM ;
Hoyt, RF ;
Arai, AE .
CIRCULATION, 2006, 113 (15) :1865-1870
[5]   Time is muscle - Translation into practice [J].
Antman, Elliott M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (15) :1216-1221
[6]   Commentary: The role of percutaneous coronary intervention in ST-Segment-Elevation myocardial infarction [J].
Bates, Eric R. ;
Nallamothu, Brahmajee K. .
CIRCULATION, 2008, 118 (05) :567-573
[7]   Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients [J].
Boersma, E .
EUROPEAN HEART JOURNAL, 2006, 27 (07) :779-788
[8]   Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging [J].
Bogaert, Jan ;
Kalantzi, Maria ;
Rademakers, Frank E. ;
Dymarkowski, Steven ;
Janssens, Stefan .
EUROPEAN RADIOLOGY, 2007, 17 (10) :2572-2580
[9]   Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR [J].
Bondarenko, O ;
Beek, AM ;
Hofman, MBM ;
Kühl, HP ;
Twisk, JWR ;
van Dockum, WG ;
Visser, CA ;
van Rossum, AC .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2005, 7 (02) :481-485
[10]   Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD trial) [J].
Brodie, Bruce R. ;
Webb, John ;
Cox, David A. ;
Qureshi, Mansoor ;
Kalynych, Anna ;
Turco, Mark ;
Schultheiss, Heinz P. ;
Dulas, Daniel ;
Rutherford, Barry ;
Antoniucci, David ;
Stuckey, Tom ;
Krucoff, Mitch ;
Gibbons, Raymond ;
Lansky, Alexandra ;
Na, Yingbo ;
Mehran, Roxana ;
Stone, Gregg W. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12) :1680-1686